We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Nexstim Oyj (NXTMH) EUR1

Sell:€8.20 Buy:€8.30 Change: €0.40 (4.65%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:€8.20
Buy:€8.30
Change: €0.40 (4.65%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:€8.20
Buy:€8.30
Change: €0.40 (4.65%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.

Contact details

Address:
Elimaenkatu 9 B
HELSINKI
00510
Finland
Telephone:
+358 (9) 2727170
Website:
https://www.nexstim.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NXTMH
ISIN:
FI4000506811
Market cap:
€61.59 million
Shares in issue:
7.16 million
Sector:
Health Care Equipment
Exchange:
Helsinki Stock Exchange
Country:
Finland
Currency:
Euro
Indices:
n/a

Key personnel

  • Leena Niemisto
    Chairman of the Board
  • Mikko Karvinen
    Chief Executive Officer, Member of the Management Board
  • Joonas Juokslahti
    Chief Financial Officer, Member of the Management Board
  • Hanna Kotola
    Vice President Legal, Quality and Regulatory Affairs; Member of the Management Team
  • Henri Hannula
    Vice President, International Sales and Marketing, Member of Management Team
  • Jarmo Laine
    Vice President, Medical Affairs, Member of the Management Team
  • Gustaf Jarnefelt
    Vice President, Research & Development; Member of the Management Team

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.